Other Clinical Guidelines
ASH provides links to the following clinical guidelines as a service to our members. The guidelines that ASH has developed can be found on the ASH Clinical Practice Guidelines page.
Clinical Practice Guidelines for Quality Palliative Care, fourth edition
The guidelines were developed by the National Consensus Project for Quality Palliative Care, comprised of 16 national organizations with extensive expertise in palliative care and hospice. On August 31, 2018, the American Society of Hematology (ASH) affirmed that these guidelines have value for hematologists. ASH did not have input into the development of these guidelines, but the final guidelines were reviewed by the ASH Working Group on Palliative Care, Guideline Oversight Subcommittee, and Committee on Quality.
ASCO Guidelines on Managing Toxicities of Checkpoint Inhibitors
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy
On June 8, 2018, the American Society of Hematology (ASH) affirmed that these guidelines have value for hematologists. The guideline panel that developed them included an ASH representative, and the final guidelines were reviewed by the ASH Task Force on Immunotherapies, Guideline Oversight Subcommittee, and Committee on Quality. ASH did not otherwise have input into the development of these guidelines.
Imaging in Pulmonary Embolism
Appropriate Use Criteria for Ventilation-Perfusion Imaging in Pulmonary Embolism
This appropriate use criteria was prepared by the Society of Nuclear Medicine and Molecular Imaging (SNMMI). On November 9, 2018, the American Society of Hematology (ASH) endorsed these appropriate use criteria. Based on this criteria, SNMMI developed the following valuable tool for physicians for determining the best diagnostic path for patients: SNMMI AUC Factsheet for Ventilation-Perfusion Imaging in Pulmonary Embolism.
McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome
On July 18, 2017, the American Society of Hematology (ASH) endorsed this guideline. This guideline for catastrophic antiphospholipid syndrome (CAPS), was prepared by the he McMaster RARE‐Bestpractices project group. The guideline panel included two ASH representatives.
Hemophilia Models of Care
National Hemophilia Foundation-McMaster University Guideline on Care Models for Hemophilia Management
This guideline was endorsed by ASH on May 27, 2016, and published in Hemophilia on June 27, 2016.
Sickle Cell Disease
Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014
This report was published by the National Heart, Lung, and Blood Institute (NHLBI) in September 2014. The report is endorsed by ASH.
Antithrombotic and Thrombolytic Therapy
The American College of Chest Physicians Evidence-based Clinical Practice Guideline on Antithrombotic Therapy and Prevention of Thrombosis (9th Edition)
This guideline was prepared by the American College of Chest Physicians and published online in the journal Chest in February 2012. This guideline is endorsed by ASH.
von Willebrand Disease
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
This guideline was prepared by the National Heart, Lung, and Blood Institute and was published online in the journal Haemophilia on February 29, 2008. ASH is providing a link to this guideline as a service to our members.
Stem Cell Research
Guidelines for the Conduct of Human Embryonic Stem Cell Research
back to top
This guideline was developed by the International Society for Stem Cell Research and is endorsed by ASH.